Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Nordic BioVentures ApS
APS
Active
CVR 43852116
Sankt Knuds Vej 22C
Activities of holding companies · NACE 6421
Est. 2023
1 employees
https://www.arc-arrow.com/
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 2,4M
-27% vs 2023
EBITDA margin
15.9%
-80% vs 2023
Equity ratio
83.5%
Financial strength
Net profit 2024
DKK 266K
-82% vs 2023
EBITDA — year on year
DKK millions
3M
2M
1M
1M
0M
2M
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
DKK 2,4M
-27%
EBITDA
DKK 378K
-80%
Net profit
DKK 266K
-82%
Total assets
DKK 2,1M
-1%
Equity
DKK 1,7M
+18%
Employees
1
—
Company information
Legal name
Nordic BioVentures ApS
CVR number
43852116
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
6. februar 2023
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede direktion.
Company purpose
Selskabets formål er at drive holdingvirksomhed.
Contact
Address
Sankt Knuds Vej 22C
Phone
+4522627767
Email
josephine@nordicbioventures.com
Website
https://www.arc-arrow.com/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of holding companies
Companies in Frederiksberg
All Denmark companies
Revenue
DKK millions
0M
1M
2M
3M
3M
3M
2023
2M
2024
EBITDA
DKK millions
0M
1M
1M
2M
2M
2M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
3.281
2.382
Staff expenses
-1.399
-2.004
EBITDA
1.883
378
Depreciation & amort.
-0
-0
EBIT
1.883
378
Net financials
10
-30
Profit before tax
1.893
348
Tax
422
82
Net profit
1.471
266
Balance sheet
DKK thousands
Item
2023
2024
Total assets
2.102
2.080
Equity
1.471
1.737
Long-term debt
0
0
Short-term debt
631
343
Total debt
631
343
Financial ratios
5-year trend
EBITDA margin
15.9%
This company
15.8%
Market median
+1% vs market
2023
2024
Equity ratio
83.5%
This company
38.2%
Market median
+119% vs market
2023
2024
Return on equity
15.3%
This company
18.4%
Market median
+17% vs market
2023
2024
Net profit margin
11.2%
This company
8.1%
Market median
+38% vs market
2023
2024
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
2023
2024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-02-06 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JS
Josephine Schrøder Warming
Management
Management
2023
WC
William Comstive Wright Nilsen
Management
Management
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Wright Ventures ApS
Company
50–66.65%
50–66.65%
2025
Warming Ventures ApS
Company
50–66.65%
50–66.65%
2025
Nordic BioVentures Holding ApS
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Warming Ventures ApS
Nordic BioVentures ApS
(this company)
Nuterials ApS
Algenius Foods ApS
Board network connections
Board members of Nordic BioVentures ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Josephine Schrøder Warming
Management
0 companies
William Comstive Wright Nilsen
Management
0 companies